BellBrook Labs
PrivateLast Round
Grant
Apr 20, 2021
Total Funding Raised
$9.68M
Company Overview
BellBrook Labs is a biotechnology company that develops biochemical assay and enzyme screening platforms to support high-throughput drug discovery for pharmaceutical and academic research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BellBrook Labs Comparables
Compare BellBrook Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BPS Bioscience | 83% | |
| AssayQuant Technologies, Inc. | 82% | |
| SIRION Biotech | 78% |
BellBrook Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 20, 2021 | ||||
| Grant | Mar 12, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | Jul 10, 2019 | ||||
| Grant | May 31, 2018 | ||||
Grant | Jul 1, 2017 |
Key People
Founding team and executive leadership
BellBrook Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 71% MoM.
- Jan 22, 2026
Monthly visitors grew 160% MoM, reaching 9.5K.
BellBrook Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BellBrook Labs's valuation, stock price, and market status.
Is BellBrook Labs a public or private company?
BellBrook Labs is a private company.
What is the current stock price of BellBrook Labs?
BellBrook Labs is a private company with no public stock price. Caplight tracks BellBrook Labs's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is BellBrook Labs worth (valuation)?
Valuation information for BellBrook Labs is not publicly available.
Can I buy BellBrook Labs stock?
BellBrook Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BellBrook Labs's last funding round?
BellBrook Labs's most recent funding round was Grant on April 20, 2021.
Who are the main investors in BellBrook Labs?
Key investors in BellBrook Labs include National Cancer Institute, National Institute of Allergy and Infectious Diseases, NIH RADx, National Institute on Alcohol Abuse and Alcoholism, National Institute of General Medical Sciences.
Will BellBrook Labs IPO soon?
No public IPO plans have been announced for BellBrook Labs.
How can I track BellBrook Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BellBrook Labs's secondary market activity and sign up for updates.